Botulinum toxin and traumatic brain injury;Toxine botulique et traumatisme crânien

Annales de Readaptation et de Medecine Physique

Volumn 46, Issue 6, 2003, Pages 303-306

  Duprey, E ^a   Dehail, P ^b   Cuny, E ^b   Arne P ^b   Fernandez, B ^b   Joseph, P A ^b   Mazaux, J M ^b   Barat, M ^b  

^a Lac de Christus   (France)

^b HÔPITAL PELLEGRIN   (France)

Author keywords

Botulinum toxin; Spasticity; Traumatic brain injury

Indexed keywords

BOTULINUM TOXIN;

BRAIN INJURY; CLINICAL FEATURE; DISEASE COURSE; DRUG INDICATION; DRUG UTILIZATION; FUNCTIONAL ASSESSMENT; HUMAN; REVIEW; SPASTICITY;

EID: 0041426754     PISSN: 01686054     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-6054(03)00108-9     Document Type: Article

References (24)

1. Autti Ramo I, Larsen A, Taimo A, Von Wendt L. Management of the upper limb with botulinum toxin type A in children with spastic type cerebral palsy and acquired brain injury: clinical implications. Eur J Neurol 2001;8(suppl 5):136-44.
2. Barat M, Mazaux JM, Daverat P, Gaujard E. Aspects cliniques du traumatisé crânien en rééducation. In: Pélissier J, Barat M, Mazaux JM, editors. Traumatisme crânien grave et médecine de rééducation. Paris: Masson; 1991. p. 101-10.
3. Cohadon F. Biomécanique et physiopathologie des lésions traumatiques à la phase aiguë. In: Pélissier J, Barat M, Mazaux JM, editors. Traumatisme crânien grave et médecine de rééducation. Paris: Masson; 1991. p. 24-38.
4. Flin C, Curalucci H, Duvocelle A, Viton JM. Para-ostéo-arthropathies neurogènes et traumatisme crânien sévère. Ann Readapt Med Phys 2002;45(9):517-20.
5. Francisco GE, Boake C, Vaughn A. Botulinum toxin in upper limb spasticity after acquired brain injury: a randomised trial comparing dilution techniques. Am J Phys Med Rehabil 2002;81(5):355-63.
6. Garland DE, Blum CE, et al. Periarticular heterotopic ossification in head-injured adults. J Bone Joint Surg Am 1980;62(7):1143-6.
7. Keren O, Reznik J, Groswasser Z. Combined motor disturbances following severe traumatic brain injury: an integrative long-term treatment approach. Brain Inj 2001;15(7):633-8.
8. Krauss JK, Trankle R, Kopp KH. Post-traumatic movement disorders in survivors of severe head injury. Neurology 1996;47(6):1488-92.
9. Krauss JK, Mohadjer M, Braus DF, Waklhoo AK, Nobbe F, Mundinger F. Dystonia following head trauma: a report of 9 patients and review of the litterature. Mov Disord 1992;7(3):263-72.
10. Lee MS, Rinne JO, Ceballos-Baumann A, Thompson PD, Marsden CD. Dystonia after head injury. Neurology 1994;44(8):1374-8.
11. Lion J, Mathé JF, Le Guiet JL. Bilan moteur et fonctionnel de prise en charge et de surveillance des traumatisés crâniens sévères. In: Pélissier J, Barat M, Mazaux JM, editors. Traumatisme crânien grave et médecine de rééducation. Paris: Masson; 1991. p. 110-5.
12. Mazaux JM, De Sèze M, Joseph PA, Barat M. Early rehabilitation after severe brain injury: a french perspective. J Rehab Med 2001;33:99-109.
13. Mazaux JM. Cranial trauma in adults in physical medecine and rehabilitation: from coma to wakefulness (short and long texts of jury recommendations). Ann Readapt Med Phys 2002;45(8):417-38.
14. Palmer DT, Horn LJ, Harmon RL. Botulinum toxin treatment of lumbrical spasticity: a brief report. Am J Phys Med Rehabil 1998;78:348-50.
15. Park ES, Park CI, Kim DY, Kim YR. The effect of spasticity on cortical somatosensory-evoked potentials after botulinum toxin type A injection. Arch Phys Med Rehabil 2002;83:1592-6.
16. Pavesi G, Brianti R, Medici D, Mammi P, Mazzuchi A, Mancia D. Botulinum toxin type A in the treatment of upper limb spasticity among patients with traumatic brain injury. J Neurol Neurosurg Psychiatry 1998;64(3):419-20.
17. Richard I, Fayard AL, Plassais R, Bernat C, Rome J, Mathé JF. La spasticité chez les traumatisés crâniens. In: Pérennou D, Bussel B, Pélissier J, editors. La spasticité. Paris: Masson; 2001. p. 226-33.
18. Silver JK, Lux WE. Early onset dystonia following traumatic head injury. Arch Phys Med Rehabil 1994;75(8):885-8.
19. Singer B, Dunne J, Allison G. Reflex and non reflex elements of hypertonia in triceps surae muscles following acquired brain injury: implications for rehabilitation. Disabil Rehabil 2001;23(17):749-57.
20. Smith SJ, Ellis E, White S, Moore AP. A double-blind placebo-controlled study of botulinum toxin in upper limb spasticity after stroke or head injury. Clin Rehabil 2000;14:5-13.
21. Tsur A, Sazbon L, Lotem M. Relationship between tone, movement and peri-articular new bone formation in postcoma-unaware (PC-U) patients. Brain Inj 1996;10(4):259-62.
22. Wilson DJ, Childers MK, Cooke DL, Smith BK. Kinematic changes following botulinum toxin injection after traumatic brain injury. Brain Injury 1997;11(3):157-67.
23. Yablon SA, Agana BT, Ivanhoe CB, Boake C. Botulinum toxin in sever upper extremity spasticity among patients with traumatic brain injury: an open-labeled trial. Neurology 1996;47(4):939-44.
24. Yablon SA. Botulinum neurotoxin intramuscular chemodenervation. Role in the management of spastic hypertonia and related motor disorders. Phys Med Rehabil Clin N Am 2001;12(4):833-74.